FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983256944> ?p ?o ?g. }

• W1983256944 endingPage "1429" @default.
• W1983256944 startingPage "1417" @default.
• W1983256944 abstract "ISIS 2302 is a 20 base phosphorothioate oligodeoxynucleotide (ODN) that inhibits intercellular adhesion molecule 1 (ICAM-1) expression through an antisense mechanism. Murine and rat analogues have been effective at doses of 0.06 - 10 mg/kg in a spectrum of models of human inflammatory diseases and allograft transplantation, and ISIS 2302 inhibits the upregulation of ICAM-1 expression in a variety of human cells in vitro. In animals, including primates, plasma distribution half-life ranges from 30 - 60 min, but tissue elimination half-lives range from 1 - 5 days, and the compound is metabolised as other nucleic acids. In a Phase I iv. study, the pharmacokinetic behaviour of ISIS 2302 was similar to that in other primates, and single and multiple every other day doses from 0.06 - 2 mg/kg infused over 2 h were well-tolerated. Phase IIa studies have been completed in Crohn’s disease, rheumatoid arthritis, and psoriasis, and a combined Phase I/II renal allograft acute rejection prophylaxis study has just completed enrolment. In these studies, ISIS 2302, 0.5 - 2 mg/kg, or placebo was administered iv. every 2 - 3 days over 14 - 26 days (7 - 13 infusions) to 17 - 52 patients, with follow up for 6 months. In the Crohn’s study, evidence of highly durable (5+ month) remission-inducing and steroid-sparing properties were demonstrated, without clinically important adverse events. A 300-patient, pivotal quality trial investigating the steroid-sparing and remission-inducing qualities of ISIS 2302 in patients with steroid-dependent Crohn’s disease is completely enrolled, with results expected in the first half of 2000. Modest efficacy and excellent tolerability were demonstrated in the psoriasis and rheumatoid arthritis trials. A Phase IIa trial of a topical formulation in patients with psoriasis is expected to commence in late 1999, as is a trial of an enema formulation in distal ulcerative colitis. Administration by nebulisation for asthma is undergoing preclinical evaluation. Execution of future plans in organ transplantation will await the results of the ongoing Phase I/II trial." @default.
• W1983256944 created "2016-06-24" @default.
• W1983256944 creator A5002331967 @default.
• W1983256944 date "1999-09-01" @default.
• W1983256944 modified "2023-09-30" @default.
• W1983256944 title "ISIS 2302, an antisense inhibitor of intercellular adhesion molecule 1" @default.
• W1983256944 cites W1578438134 @default.
• W1983256944 cites W1965411838 @default.
• W1983256944 cites W1965742429 @default.
• W1983256944 cites W1971291006 @default.
• W1983256944 cites W1975568484 @default.
• W1983256944 cites W1984718218 @default.
• W1983256944 cites W1985137297 @default.
• W1983256944 cites W1992041806 @default.
• W1983256944 cites W1995948010 @default.
• W1983256944 cites W1996472975 @default.
• W1983256944 cites W1999855196 @default.
• W1983256944 cites W2013283804 @default.
• W1983256944 cites W2015037737 @default.
• W1983256944 cites W2017761250 @default.
• W1983256944 cites W2022234757 @default.
• W1983256944 cites W2023095312 @default.
• W1983256944 cites W2027809685 @default.
• W1983256944 cites W2028146382 @default.
• W1983256944 cites W2028965877 @default.
• W1983256944 cites W2031524509 @default.
• W1983256944 cites W2032494769 @default.
• W1983256944 cites W2033312306 @default.
• W1983256944 cites W2034077952 @default.
• W1983256944 cites W2036242475 @default.
• W1983256944 cites W2041452685 @default.
• W1983256944 cites W2041776029 @default.
• W1983256944 cites W2044422939 @default.
• W1983256944 cites W2048462515 @default.
• W1983256944 cites W2050286820 @default.
• W1983256944 cites W2051354793 @default.
• W1983256944 cites W2055555162 @default.
• W1983256944 cites W2057784785 @default.
• W1983256944 cites W2058165751 @default.
• W1983256944 cites W2067327580 @default.
• W1983256944 cites W2072251818 @default.
• W1983256944 cites W2073383011 @default.
• W1983256944 cites W2078880063 @default.
• W1983256944 cites W2079748356 @default.
• W1983256944 cites W2083172750 @default.
• W1983256944 cites W2093830420 @default.
• W1983256944 cites W2113296405 @default.
• W1983256944 cites W2116925086 @default.
• W1983256944 cites W2117837558 @default.
• W1983256944 cites W2122980035 @default.
• W1983256944 cites W2156676347 @default.
• W1983256944 cites W2158378586 @default.
• W1983256944 cites W2163809288 @default.
• W1983256944 cites W2314052274 @default.
• W1983256944 cites W2326330820 @default.
• W1983256944 cites W2344640730 @default.
• W1983256944 cites W3023076263 @default.
• W1983256944 cites W3149527659 @default.
• W1983256944 cites W68282923 @default.
• W1983256944 cites W92700363 @default.
• W1983256944 doi "https://doi.org/10.1517/13543784.8.9.1417" @default.
• W1983256944 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15992159" @default.
• W1983256944 hasPublicationYear "1999" @default.
• W1983256944 type Work @default.
• W1983256944 sameAs 1983256944 @default.
• W1983256944 citedByCount "14" @default.
• W1983256944 countsByYear W19832569442012 @default.
• W1983256944 countsByYear W19832569442013 @default.
• W1983256944 countsByYear W19832569442014 @default.
• W1983256944 countsByYear W19832569442017 @default.
• W1983256944 countsByYear W19832569442023 @default.
• W1983256944 crossrefType "journal-article" @default.
• W1983256944 hasAuthorship W1983256944A5002331967 @default.
• W1983256944 hasConcept C112705442 @default.
• W1983256944 hasConcept C126322002 @default.
• W1983256944 hasConcept C142724271 @default.
• W1983256944 hasConcept C185592680 @default.
• W1983256944 hasConcept C197934379 @default.
• W1983256944 hasConcept C203014093 @default.
• W1983256944 hasConcept C204787440 @default.
• W1983256944 hasConcept C27081682 @default.
• W1983256944 hasConcept C2776914184 @default.
• W1983256944 hasConcept C2777575956 @default.
• W1983256944 hasConcept C2909375385 @default.
• W1983256944 hasConcept C2911091166 @default.
• W1983256944 hasConcept C71924100 @default.
• W1983256944 hasConcept C98274493 @default.
• W1983256944 hasConceptScore W1983256944C112705442 @default.
• W1983256944 hasConceptScore W1983256944C126322002 @default.
• W1983256944 hasConceptScore W1983256944C142724271 @default.
• W1983256944 hasConceptScore W1983256944C185592680 @default.
• W1983256944 hasConceptScore W1983256944C197934379 @default.
• W1983256944 hasConceptScore W1983256944C203014093 @default.
• W1983256944 hasConceptScore W1983256944C204787440 @default.
• W1983256944 hasConceptScore W1983256944C27081682 @default.
• W1983256944 hasConceptScore W1983256944C2776914184 @default.
• W1983256944 hasConceptScore W1983256944C2777575956 @default.
• W1983256944 hasConceptScore W1983256944C2909375385 @default.

• next